Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Jan;75(1):67–71. doi: 10.1136/hrt.75.1.67

Pericardial effusion in patients with cancer: outcome with contemporary management strategies.

R J Laham 1, D J Cohen 1, R E Kuntz 1, D S Baim 1, B H Lorell 1, M Simons 1
PMCID: PMC484225  PMID: 8624876

Abstract

OBJECTIVE--To investigate the clinical presentation and current management strategies of pericardial effusion in patients with malignancy. DESIGN--Retrospective single centre, consecutive observational study. SETTING--University hospital. PATIENTS--93 consecutive patients with a past or present diagnosis of cancer and a pericardial effusion, including 50 with a pericardial effusion > 1 cm. RESULTS--Of the 50 patients with pericardial effusions > 1 cm, most had stage 4 cancer (64%), were symptomatic at the time of presentation (74%), and had right atrial collapse (74%). Twenty patients were treated conservatively (without pericardiocentesis) and were less symptomatic (55% v 87%, P = 0.012), had smaller pericardial effusions (1.5 (0.4) v 1.8 (0.5), P = 0.02), and less frequent clinical (10% v 40%, P = 0.02) and echocardiographic evidence of tamponade (40% v 97%, P < 0.001) than the 30 patients treated invasively with initial pericardiocentesis (n = 29) or pericardial window placement (n = 1). Pericardial tamponade requiring repeat pericardiocentesis occurred in 18 (62%) of 29 patients after a median of 7 days. In contrast, only four (20%) of 20 patients in the conservative group progressed to frank clinical tamponade and required pericardiocentesis (P = 0.005 v invasive group). The overall median survival was 2 months with a survival rate at 48 months of 26%. Survival, duration of hospital stay, and hospital charges were similar with both strategies. By multivariable analysis, the absence of symptoms was the only independent predictor of long-term survival (relative hazards ratio = 3.2, P = 0.05). Survival was similar in the 43 patients with cancer and pericardial effusions of < or = 1 cm. CONCLUSION--Asymptomatic patients with cancer and pericardial effusion can be managed conservatively with close follow up. In patients with symptoms or clinical cardiac tamponade, pericardiocentesis provides relief of symptoms but does not improve survival and has a high recurrence rate. Surgical pericardial windows or possibly percutaneous balloon pericardiotomy should be used for recurrences and should be considered for initial treatment.

Full text

PDF
67

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agner R. C., Gallis H. A. Pericarditis: differential diagnostic considerations. Arch Intern Med. 1979 Apr;139(4):407–412. doi: 10.1001/archinte.139.4.407. [DOI] [PubMed] [Google Scholar]
  2. Appelqvist P., Maamies T., Gröhn P. Emergency pericardiotomy as primary diagnostic and therapeutic procedure in malignant pericardial tamponade: report of three cases and review of the literature. J Surg Oncol. 1982 Sep;21(1):18–22. doi: 10.1002/jso.2930210105. [DOI] [PubMed] [Google Scholar]
  3. Biran S., Hochman A., Levij I. S., Stern S. Clinical diagnosis of secondary tumors of the heart and pericardium. Dis Chest. 1969 Mar;55(3):202–208. doi: 10.1378/chest.55.3.202. [DOI] [PubMed] [Google Scholar]
  4. Buck M., Ingle J. N., Giuliani E. R., Gordon J. R., Therneau T. M. Pericardial effusion in women with breast cancer. Cancer. 1987 Jul 15;60(2):263–269. doi: 10.1002/1097-0142(19870715)60:2<263::aid-cncr2820600225>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  5. Cham W. C., Freiman A. H., Carstens P. H., Chu F. C. Radiation therapy of cardiac and pericardial metastases. Radiology. 1975 Mar;114(3):701–704. doi: 10.1148/114.3.701. [DOI] [PubMed] [Google Scholar]
  6. Chow W. H., Chow T. C., Cheung K. L. Nonsurgical creation of a pericardial window using the Inoue balloon catheter. Am Heart J. 1992 Oct;124(4):1100–1102. doi: 10.1016/0002-8703(92)91006-m. [DOI] [PubMed] [Google Scholar]
  7. Davis S., Sharma S. M., Blumberg E. D., Kim C. S. Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion. N Engl J Med. 1978 Nov 16;299(20):1113–1114. doi: 10.1056/NEJM197811162992006. [DOI] [PubMed] [Google Scholar]
  8. Engel P. J., Hon H., Fowler N. O., Plummer S. Echocardiographic study of right ventricular wall motion in cardiac tamponade. Am J Cardiol. 1982 Nov;50(5):1018–1021. doi: 10.1016/0002-9149(82)90411-8. [DOI] [PubMed] [Google Scholar]
  9. Gregory J. R., McMurtrey M. J., Mountain C. F. A surgical approach to the treatment of pericardial effusion in cancer patients. Am J Clin Oncol. 1985 Aug;8(4):319–323. doi: 10.1097/00000421-198508000-00009. [DOI] [PubMed] [Google Scholar]
  10. Hawkins J. W., Vacek J. L. What constitutes definitive therapy of malignant pericardial effusion? "Medical" versus surgical treatment. Am Heart J. 1989 Aug;118(2):428–432. doi: 10.1016/0002-8703(89)90214-7. [DOI] [PubMed] [Google Scholar]
  11. Jackson G., Keane D., Mishra B. Percutaneous balloon pericardiotomy in the management of recurrent malignant pericardial effusions. Br Heart J. 1992 Dec;68(6):613–615. doi: 10.1136/hrt.68.12.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kline I. K. Cardiac lymphatic involvement by metastatic tumor. Cancer. 1972 Mar;29(3):799–808. doi: 10.1002/1097-0142(197203)29:3<799::aid-cncr2820290338>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  13. Krikorian J. G., Hancock E. W. Pericardiocentesis. Am J Med. 1978 Nov;65(5):808–814. doi: 10.1016/0002-9343(78)90800-8. [DOI] [PubMed] [Google Scholar]
  14. Levine M. J., Lorell B. H., Diver D. J., Come P. C. Implications of echocardiographically assisted diagnosis of pericardial tamponade in contemporary medical patients: detection before hemodynamic embarrassment. J Am Coll Cardiol. 1991 Jan;17(1):59–65. doi: 10.1016/0735-1097(91)90704-d. [DOI] [PubMed] [Google Scholar]
  15. Lokich J. J. The management of malignant pericardial effusions. JAMA. 1973 Jun 4;224(10):1401–1404. [PubMed] [Google Scholar]
  16. Okamoto H., Shinkai T., Yamakido M., Saijo N. Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion. Cancer. 1993 Jan 1;71(1):93–98. doi: 10.1002/1097-0142(19930101)71:1<93::aid-cncr2820710115>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  17. Palacios I. F., Tuzcu E. M., Ziskind A. A., Younger J., Block P. C. Percutaneous balloon pericardial window for patients with malignant pericardial effusion and tamponade. Cathet Cardiovasc Diagn. 1991 Apr;22(4):244–249. doi: 10.1002/ccd.1810220403. [DOI] [PubMed] [Google Scholar]
  18. Park J. S., Rentschler R., Wilbur D. Surgical management of pericardial effusion in patients with malignancies. Comparison of subxiphoid window versus pericardiectomy. Cancer. 1991 Jan 1;67(1):76–80. doi: 10.1002/1097-0142(19910101)67:1<76::aid-cncr2820670115>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  19. Piehler J. M., Pluth J. R., Schaff H. V., Danielson G. K., Orszulak T. A., Puga F. J. Surgical management of effusive pericardial disease. Influence of extent of pericardial resection on clinical course. J Thorac Cardiovasc Surg. 1985 Oct;90(4):506–516. [PubMed] [Google Scholar]
  20. Posner M. R., Cohen G. I., Skarin A. T. Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med. 1981 Sep;71(3):407–413. doi: 10.1016/0002-9343(81)90168-6. [DOI] [PubMed] [Google Scholar]
  21. Quraishi M. A., Costanzi J. J., Hokanson J. The natural history of lung cancer with pericardial metastases. Cancer. 1983 Feb 15;51(4):740–742. doi: 10.1002/1097-0142(19830215)51:4<740::aid-cncr2820510431>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  22. Shepherd F. A., Morgan C., Evans W. K., Ginsberg J. F., Watt D., Murphy K. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol. 1987 Nov 15;60(14):1161–1166. doi: 10.1016/0002-9149(87)90411-5. [DOI] [PubMed] [Google Scholar]
  23. Singh S., Wann L. S., Schuchard G. H., Klopfenstein H. S., Leimgruber P. P., Keelan M. H., Jr, Brooks H. L. Right ventricular and right atrial collapse in patients with cardiac tamponade--a combined echocardiographic and hemodynamic study. Circulation. 1984 Dec;70(6):966–971. doi: 10.1161/01.cir.70.6.966. [DOI] [PubMed] [Google Scholar]
  24. Sugimoto J. T., Little A. G., Ferguson M. K., Borow K. M., Vallera D., Staszak V. M., Weinert L. Pericardial window: mechanisms of efficacy. Ann Thorac Surg. 1990 Sep;50(3):442–445. doi: 10.1016/0003-4975(90)90491-n. [DOI] [PubMed] [Google Scholar]
  25. Vaitkus P. T., Herrmann H. C., LeWinter M. M. Treatment of malignant pericardial effusion. JAMA. 1994 Jul 6;272(1):59–64. [PubMed] [Google Scholar]
  26. Wong B., Murphy J., Chang C. J., Hassenein K., Dunn M. The risk of pericardiocentesis. Am J Cardiol. 1979 Nov;44(6):1110–1114. doi: 10.1016/0002-9149(79)90176-0. [DOI] [PubMed] [Google Scholar]
  27. Yazdi H. M., Hajdu S. I., Melamed M. R. Cytopathology of pericardial effusions. Acta Cytol. 1980 Sep-Oct;24(5):401–412. [PubMed] [Google Scholar]
  28. Zipf R. E., Jr, Johnston W. W. The role of cytology in the evaluation of pericardial effusions. Chest. 1972 Nov;62(5):593–596. doi: 10.1378/chest.62.5.593. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES